Stock 3737 ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Delayed Hong Kong S.E.
Other stock markets
 04:09:05 2024-06-07 am EDT 		5-day change 1st Jan Change
1.04 HKD +0.97% Intraday chart for Zhongzhi Pharmaceutical Holdings Limited +4.00% -26.76%
Mar. 25 Zhongzhi Pharmaceutical's Attributable Jumps in 2023 MT
Mar. 22 Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend
CI
Zhongzhi Pharmaceutical's Attributable Jumps in 2023
MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024
CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit
MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend
CI
Zhongzhi Pharmaceutical’s Profit Up 75% in H1
MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 2 November 2023
CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%
MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023
CI
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory
MT
Zhongshan Hengsheng Enters into the Construction Contract with Shenzhen Xinmei
CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Special Dividend
CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend
CI
Zhongzhi Pharmaceutical Holdings Limited Proposes Special Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023
CI
Zhongzhi Pharmaceutical Holdings Limited Proposes Payment of Final Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023
CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Zhongzhi Pharmaceutical Sees Twofold Jump in FY22 Profit
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3737 Stock
  4. News Zhongzhi Pharmaceutical Holdings Limited